Nepal grants emergency use approval to Pfizer-BioNTech’s bivalent vaccine

Due to the delay in giving permission, supply of the vaccine by Covax could not start on time.

Amid the increasing risk of a new surge in Covid infections, a meeting of the Drug Advisory Committee on Tuesday granted emergency use approval to Pfizer-BioNtech’s bivalent vaccine.